IL-6 cytokine is debatable as progressive decline in IL-6 has been observed in Long COVID or in recovered COVID-19 patients and is therefore considered a marker of the acute phase of the disease (Queiroz et al. 2022; Yong et al. 2023). Here, IL6 is linked to COVID-19.